• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人干扰素α1和α2与人和牛细胞上共同受体的不同结合。对大肠杆菌中产生的重组干扰素的研究。

Different binding of human interferon alpha 1 and alpha 2 to common receptors on human and bovine cells. Studies with recombination interferons produced in Escherichia coli.

作者信息

Yonehara S, Yonehara-Takahashi M, Ishii A, Nagata S

出版信息

J Biol Chem. 1983 Aug 10;258(15):9046-9.

PMID:6307990
Abstract

Minicells from Escherichia coli DS410 harboring cDNA for human interferon (IFN) alpha 1 or alpha 2 were metabolically labeled with [3H]leucine and the radioactive IFN was purified to homogeneity by immune precipitation with anti-IFN-alpha serum. These preparations of radioactive IFN-alpha 1 and -alpha 2 were used to study the binding on two human (FL and Daudi) and one bovine (MDBK) cell lines. IFN-alpha 2 specifically bound well to both human and bovine cells, while IFN-alpha 1 bound very poorly to human cells but well to bovine cells. Specific binding of radioactive IFN-alpha 2 to these cell lines was completely inhibited by not only nonradioactive IFN-alpha 2 but also IFN-alpha 1, and binding of IFN-alpha 1 to bovine cell was also competed by IFN-alpha 2 as well as IFN-alpha 1, indicating that the receptors for both IFNs are identical. However, 50-100-fold (on human cells) or 4-fold (on bovine cell) more nonradioactive IFN-alpha 1 than -alpha 2 was required to inhibit the binding of radioactive IFN-alpha 2 to the receptors. Scatchard analysis showed that IFN-alpha 1 and -alpha 2 bind to the receptors on human cells with an apparent Kd of greater than 6 X 10(-10) and 3 X 10(-11) M, respectively, while on bovine cells with a Kd of 4.2 X 10(-11) and 1.6 X 10(-11) M, respectively. These results show that the different target cell specificity of IFN-alpha 1 and -alpha 2 in regard to antiviral activity (Streuli, M., Hall, A., Boll, W., Stewart, W. E., II, Nagata, S., and Weissmann, C. (1981) Proc. Natl. Acad. Sci. U. S. A. 78, 2848-2852) is due to the different binding activity of IFN-alpha molecules to their common receptors.

摘要

携带人α1或α2干扰素(IFN)cDNA的大肠杆菌DS410产生的微细胞用[3H]亮氨酸进行代谢标记,放射性IFN通过用抗IFN-α血清进行免疫沉淀纯化至同质。这些放射性IFN-α1和-α2制剂用于研究在两个人类细胞系(FL和Daudi)和一个牛细胞系(MDBK)上的结合情况。IFN-α2与人细胞和牛细胞都能很好地特异性结合,而IFN-α1与人细胞的结合非常差,但与牛细胞结合良好。放射性IFN-α2与这些细胞系的特异性结合不仅被非放射性IFN-α2完全抑制,也被IFN-α1完全抑制,并且IFN-α1与牛细胞的结合也被IFN-α2以及IFN-α1竞争,这表明两种IFN的受体是相同的。然而,抑制放射性IFN-α2与受体的结合所需的非放射性IFN-α1比IFN-α2多50 - 100倍(在人细胞上)或4倍(在牛细胞上)。Scatchard分析表明,IFN-α1和-α2与人细胞受体结合的表观解离常数(Kd)分别大于6×10^(-10)和3×10^(-11) M,而与牛细胞受体结合的Kd分别为4.2×10^(-11)和1.6×10^(-11) M。这些结果表明,就抗病毒活性而言(斯特雷利,M.,霍尔,A.,博尔,W.,斯图尔特,W.E.二世,永田,S.,和魏斯曼,C.(1981年)《美国国家科学院院刊》78,2848 - 2852),IFN-α1和-α2不同的靶细胞特异性是由于IFN-α分子与其共同受体的结合活性不同。

相似文献

1
Different binding of human interferon alpha 1 and alpha 2 to common receptors on human and bovine cells. Studies with recombination interferons produced in Escherichia coli.人干扰素α1和α2与人和牛细胞上共同受体的不同结合。对大肠杆菌中产生的重组干扰素的研究。
J Biol Chem. 1983 Aug 10;258(15):9046-9.
2
Specific binding of human alpha interferon to a high affinity cell surface binding site on bovine kidney cells.人α干扰素与牛肾细胞上高亲和力细胞表面结合位点的特异性结合。
J Biol Chem. 1982 May 10;257(9):4695-7.
3
Binding of human interferon alpha to cells of different sensitivities: studies with internally radiolabeled interferon retaining full biological activity.人α干扰素与不同敏感性细胞的结合:对保留完全生物活性的内部放射性标记干扰素的研究
J Virol. 1983 Mar;45(3):1168-71. doi: 10.1128/JVI.45.3.1168-1171.1983.
4
Orientation of a human leukocyte interferon molecule on its cell surface receptor: carboxyl terminus remains accessible to a monoclonal antibody made against a synthetic interferon fragment.人白细胞干扰素分子在其细胞表面受体上的取向:羧基末端对于针对合成干扰素片段制备的单克隆抗体仍可及。
Proc Natl Acad Sci U S A. 1983 May;80(9):2539-43. doi: 10.1073/pnas.80.9.2539.
5
Various human interferon alpha subclasses cross-react with common receptors: their binding affinities correlate with their specific biological activities.多种人干扰素α亚类与共同受体发生交叉反应:它们的结合亲和力与其特定生物学活性相关。
Virology. 1984 Jan 15;132(1):211-6. doi: 10.1016/0042-6822(84)90105-3.
6
Internalization and degradation of human alpha-A interferon bound to bovine MDBK cells: regulation of the decay and resynthesis of receptors.与牛MDBK细胞结合的人α-A干扰素的内化与降解:受体衰变与再合成的调控
J Interferon Res. 1983;3(4):465-71. doi: 10.1089/jir.1983.3.465.
7
[Receptor system of interferons].
Gan To Kagaku Ryoho. 1984 Jan;11(1):44-52.
8
Characterization and regulation of alpha-interferon receptor expression in interferon-sensitive and -resistant human lymphoblastoid cells.干扰素敏感和耐药的人淋巴母细胞中α-干扰素受体表达的特征及调控
J Biol Chem. 1984 Aug 10;259(15):9456-60.
9
Kinetic evidence for an activation step following binding of human interferon alpha 2 to the membrane receptors of Daudi cells.
Eur J Biochem. 1983 Aug 1;134(2):355-64. doi: 10.1111/j.1432-1033.1983.tb07575.x.
10
Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons.大肠杆菌衍生的人α、β和γ干扰素的协同抗病毒和抗增殖活性。
J Virol. 1984 Feb;49(2):490-6. doi: 10.1128/JVI.49.2.490-496.1984.

引用本文的文献

1
S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) monoclonal antibody as a candidate treatment for selected autoimmune rheumatic diseases.S95021,一种新型的选择性全中和抗α干扰素(IFN-α)单克隆抗体,作为特定自身免疫性风湿性疾病的候选治疗药物。
J Transl Autoimmun. 2021 Mar 1;4:100093. doi: 10.1016/j.jtauto.2021.100093. eCollection 2021.
2
Receptors for human alpha and beta interferon but not for gamma interferon are specified by human chromosome 21.人类α干扰素和β干扰素的受体由人类21号染色体决定,而γ干扰素的受体并非如此。
Proc Natl Acad Sci U S A. 1984 Sep;81(17):5504-8. doi: 10.1073/pnas.81.17.5504.
3
The nature of neutralization reaction between effector protein and monoclonal antibody: a quantitative study of neutralization characteristics of anti-interferon antibodies.
效应蛋白与单克隆抗体之间中和反应的性质:抗干扰素抗体中和特性的定量研究
Immunology. 1985 Nov;56(3):489-95.
4
Receptor dynamics of closely related ligands: "fast' and "slow' interferons.密切相关配体的受体动力学:“快速”和“慢速”干扰素
EMBO J. 1985 Jan;4(1):65-70. doi: 10.1002/j.1460-2075.1985.tb02318.x.
5
A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.一种针对与肿瘤坏死因子受体共同下调的细胞表面抗原的细胞杀伤性单克隆抗体(抗Fas)。
J Exp Med. 1989 May 1;169(5):1747-56. doi: 10.1084/jem.169.5.1747.
6
Interferon receptors.干扰素受体
In Vitro Cell Dev Biol. 1988 Mar;24(3):155-65. doi: 10.1007/BF02623541.
7
Regulation of cell growth by interferon.干扰素对细胞生长的调节
Cancer Metastasis Rev. 1987;6(3):199-221. doi: 10.1007/BF00144264.
8
Neutralization of activity of effector protein by monoclonal antibody: formulation of antibody dose-dependence of neutralization for an equilibrium system of antibody, effector, and its cellular receptor.单克隆抗体对效应蛋白活性的中和作用:针对抗体、效应物及其细胞受体平衡系统的中和抗体剂量依赖性的公式化表述。
Immunology. 1985 Nov;56(3):497-504.
9
Cytokines regulating acute inflammation and synthesis of acute phase proteins.调节急性炎症和急性期蛋白合成的细胞因子。
Blut. 1985 Oct;51(4):267-74. doi: 10.1007/BF00320521.